Sean McGeehan

Sean has over 20 years of experience in the life science and medical device industries. His collective corporate and patent experience is a tremendous asset to AtaCor Medical and has resulted in numerous U.S. and international patents specific to AtaCor’s technology.

Previously, at Cameron Health, Sean developed and executed an IP strategy for obtaining and leveraging global patent protection and avoiding IP risks for a novel subcutaneous implantable defibrillator system (S-ICD) and was responsible for raising a total of $228M in equity ($183M) and debt financing ($45M). He further provided counsel through all stages of Cameron Health’s growth, including venture capital financings, clinical and regulatory matters, and the company’s acquisition by Boston Scientific in 2012.

Sean has also worked as an attorney at multi-national law firms, (Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP and Brobeck, Phleger & Harrison, LLP), where he advised venture capital funds and venture capital-backed emerging companies on fundraising, governance, and investment activities.

Sean earned a BSc degree in Microbiology from The Ohio State University, a BSc degree in Chemistry from the University of Minnesota (Institute of Technology) and a J.D. from the University of Minnesota Law School.